Molecular mechanisms of primary resistance to flucytosine in Candida albicans

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 11, 2004, Pages 4377-4386

  Hope, William W ^a,b   Tabernero, Lydia ^a   Denning, David W ^a   Anderson, Michael J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ASPARTIC ACID; CYSTEINE; CYTIDINE PHOSPHATE; CYTOSINE; CYTOSINE DEAMINASE; FLUCYTOSINE; GLYCINE; NUCLEOTIDE; PERMEASE; PURINE; PYRIMIDINE; THYMIDINE PHOSPHATE; URACIL PHOSPHORIBOSYLTRANSFERASE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDA ALBICANS; ENZYME ACTIVITY; FCA1 GENE; FCY21 GENE; FCY22 GENE; FUNGAL STRAIN; FUNGUS ISOLATION; FUR1 GENE; GENE; GENE SEQUENCE; GENETIC POLYMORPHISM; HOMOZYGOSITY; MOLECULAR MODEL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN QUATERNARY STRUCTURE;

AMINO ACID SEQUENCE; ANTIFUNGAL AGENTS; ANTIMETABOLITES; CANDIDA ALBICANS; CYTOSINE DEAMINASE; DNA PRIMERS; DNA, FUNGAL; DRUG RESISTANCE, FUNGAL; FLUCYTOSINE; FLUOROURACIL; GENES, FUNGAL; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PENTOSYLTRANSFERASES; POLYMORPHISM, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SACCHAROMYCES CEREVISIAE PROTEINS;

EID: 7244238101     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.11.4377-4386.2004     Document Type: Article

References (28)

1. Barchiesi, F., D. Arzeni, F. Caselli, and G. Scalise. 2000. Primary resistance to flucytosine among clinical isolates of Candida spp. J. Antimicrob. Chemother. 45:408-409.
2. Dodgson, A. R., K. J. Dodgson, C. Pujol, M. A. Pfaller, and D. R. Soil. 2004. Clade-specific flucytosine resistance is due to single nucleotide change in the FUR1 gene of Candida albicans. Antimicrob. Agents Chemother. 48:2223-2227.
3. Erbs, P., F. Exinger, and R. Jund. 1997. Characterization of the Saccharomyces cerevisiae FCY1 gene encoding cytosine deaminase and its homologue FCA1 of Candida albicans. Curr. Genet. 31:1-6.
4. Fasoli, M., and D. Kerridge. 1988. Isolation and characterization of fluoropyrimidine-resistant mutants in two Candida species. Ann. N. Y. Acad. Sci. 544:260-263.
5. Henikoff, S., and J. G. Henikoff. 1992. Amino acid substitution matrices from protein blocks. Proc. Natl. Acad. Sci. USA 89:10915-10919.
6. Jensen, H. K., N. Mikkelsen, and J. Neuhard. 1997. Recombinant uracil phosphoribosyltransferase from the thermophile Bacillus caldolyticus: expression, purification, and partial characterization. Protein Expr. Purif. 10: 356-364.
7. Journal of Antimicrobial Chemotherapy. 1984. Laboratory methods for flucytosine (5-fluorocytosine). Report of a Working Group of the British Society for Mycopathology. J Antimicrob. Chemother. 14:1-8.
8. Jund, R., and F. Lacroute. 1970. Genetic and physiological aspects of resistance to 5-fluoropyrimidines in Saccharomyces cerevisiae. J. Bacteriol. 102: 607-615.
9. Kern, L., J. de Montigny, R. Jund, and F. Lacroute. 1990. The FUR1 gene of Saccharomyces cerevisiae: cloning, structure and expression of wild-type and mutant alleles. Gene 88:149-157.
10. Kern, L., J. de Montigny, F. Lacroute, and R. Jund. 1991. Regulation of the pyrimidine salvage pathway by the FUR1 gene product of Saccharomyces cerevisiae. Curr. Genet. 19:333-337.
11. Kimura, M. 1983. The neutral theory of molecular evolution. Cambridge University Press, Cambridge, United Kingdom.
12. Lee, C., and K. Perry. 2001. The GeneMine system for genome/proteome annotation and collaborative data mining. IBM Syst. J. 40:592-603.
13. Natalini, P., S. Ruggieri, I. Santarelli, A. Vita, and G. Magni. 1979. Baker's yeast UMP:pyrophosphate phosphoribosyltransferase. Purification, enzymatic and kinetic properties. J. Biol. Chem. 254:1558-1563.
14. Normark, S., and J. Schonebeck. 1973. In vitro studies of 5-fluorocytosine resistance in Candida albicans and Torulopsis glabrata. Antimicrob. Agents Chemother. 2:114-121.
15. Page, R. D. 1996, TreeView: an application to display phylogenetic trees on personal computers. Comput. Appl. Biosci. 12:357-358.
16. Pfaller, M. A., S. A. Messer, L. Boyken, H. Huynh, R. J. Hollis, and D. J. Diekema. 2002. In vitro activities of 5-fluorocytosine against 8,803 clinical isolates of Candida spp.: global assessment of primary resistance using National Committee for Clinical Laboratory Standards susceptibility testing methods. Antimicrob. Agents Chemother. 46:3518-3521.
17. Polak, A., and H. J. Scholer. 1975. Mode of action of 5-fluorocytosine and mechanisms of resistance. Chemotherapy 21:113-130.
18. Polak, A., and W. H. Wain. 1977. The influence of 5-fluorocytosine on nucleic acid synthesis in Candida albicans, Cryptococcus neoformans, and Aspergillus fumigatus. Chemotherapy 23:243-259.
19. Pujol, C., M. A. Pfaller, and D. R. Soll. 2004. Flucytosine resistance is restricted to a single genetic clade of Candida albicans. Antimicrob. Agents Chemother. 48:262-266.
20. Rodriguez-Tudela, J. L., F. Barchiesi, J. Bille, E. Chryssanthou, M. Cuenca-Estrella, D. Denning, J. P. Donnelly, B. Dupont, W. Fegeler, C. Moore, M. Richardson, and P. E. Verwiej. 2003. Method for the determination of minimum inhibitory concentration (MIC) by broth dilution of fermentative yeasts. Clin. Microbiol. Infect. 9:i-vii.
21. Schmidt, R., M. F. Manolson, and M. R. Chevallier. 1984. Photoaffinity labeling and characterization of the cloned purine-cytosine transport system in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 81:6276-6280.
22. Schumacher, M. A., C. J. Bashor, M. H. Song, K. Otsu, S. Zhu, R. J. Parry, B. Ullman, and R. G. Brennan. 2002. The structural mechanism of GTP stabilized oligomerization and catalytic activation of the Toxoplasma gondii uracil phosphoribosyltransferase. Proc. Natl. Acad. Sci. USA 99:78-83.
23. Schumacher, M. A., D. Carter, D. M. Scott, D. S. Roos, B. Ullman, and R. G. Brennan. 1998. Crystal structures of Toxoplasma gondii uracil phosphoribosyltransferase reveal the atomic basis of pyrimidine discrimination and prodrug binding. EMBO J. 17:3219-3232.
24. Stolz, J., and M. Vielreicher. 2003. Tpn1p, the plasma membrane vitamin B6 transporter of Saccharomyces cerevisiae. J. Biol. Chem. 278:18990-18996.
25. Vermes, A., H. J. Guchelaar, and J. Dankert. 2000. Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. J. Antimicrob. Chemother. 46:171-179.
26. Waldorf, A. R., and A. Polak. 1983. Mechanisms of action of 5-fluorocytosine. Antimicrob. Agents Chemother. 23:79-85.
27. Weber, E., C. Rodriguez, M. R. Chevallier, and R. Jund. 1990. The purine-cytosine permease gene of Saccharomyces cerevisiae: primary structure and deduced protein sequence of the FCY2 gene product. Mol. Microbiol. 4:585-596.
28. Whelan, W. L., and D. Kerridge. 1984. Decreased activity of UMP pyrophosphorylase associated with resistance to 5-fluorocytosine in Candida albicans. Antimicrob. Agents Chemother. 26:570-574.